{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:16:10Z","timestamp":1790946970244,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL123920, HL137093, HL144002, HL146153, HL147357, and HL149940"],"award-info":[{"award-number":["HL123920, HL137093, HL144002, HL146153, HL147357, and HL149940"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18TPA34230092 and 19EIA34660286"],"award-info":[{"award-number":["18TPA34230092 and 19EIA34660286"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41565-021-00923-2","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T12:06:53Z","timestamp":1623931613000},"page":"942-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9751-0864","authenticated-orcid":false,"given":"Zhenhua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-6256","authenticated-orcid":false,"given":"Phuong-Uyen C.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4645-5786","authenticated-orcid":false,"given":"Dashuai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6341-2251","authenticated-orcid":false,"given":"Kristen D.","family":"Popowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6364-7627","authenticated-orcid":false,"given":"Halle","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Greenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Pessaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard J.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8053-7059","authenticated-orcid":false,"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"923_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. Lancet 395, 470\u2013473 (2020).","journal-title":"Lancet"},{"key":"923_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061\u20131069 (2020).","journal-title":"JAMA"},{"key":"923_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijid.2020.01.050","volume":"92","author":"S Zhao","year":"2020","unstructured":"Zhao, S. et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int. J. Infect. Dis. 92, 214\u2013217 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"923_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijid.2020.03.050","volume":"95","author":"J Yuan","year":"2020","unstructured":"Yuan, J., Li, M., Lv, G. & Lu, Z. K. Monitoring transmissibility and mortality of COVID-19 in Europe. Int. J. Infect. Dis. 95, 311\u2013315 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"923_CR5","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016\u20131035.e19 (2020).","journal-title":"Cell"},{"key":"923_CR6","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.5966\/sctm.2015-0062","volume":"4","author":"E Henry","year":"2015","unstructured":"Henry, E. et al. Adult lung spheroid cells contain progenitor cells and mediate regeneration in rodents with bleomycin-induced pulmonary fibrosis. Stem Cells Transl. Med. 4, 1265\u20131274 (2015).","journal-title":"Stem Cells Transl. Med."},{"key":"923_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12931-017-0611-0","volume":"18","author":"PC Dinh","year":"2017","unstructured":"Dinh, P. C. et al. Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies. Respir. Res. 18, 132 (2017).","journal-title":"Respir. Res."},{"key":"923_CR8","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/sctm.16-0374","volume":"6","author":"J Cores","year":"2017","unstructured":"Cores, J. et al. Safety and efficacy of allogeneic lung spheroid cells in a mismatched rat model of pulmonary fibrosis. Stem Cells Transl. Med. 6, 1905\u20131916 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"923_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14344-7","volume":"11","author":"P-UC Dinh","year":"2020","unstructured":"Dinh, P.-U. C. et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat. Commun. 11, 1064 (2020).","journal-title":"Nat. Commun."},{"key":"923_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14728222.2020.1820482","volume":"17","author":"S Jiang","year":"2020","unstructured":"Jiang, S., Zhang, X. & Du, L. Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2. Expert Opin. Ther. Targets 17, 1\u20137 (2020).","journal-title":"Expert Opin. Ther. Targets"},{"key":"923_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","volume":"182","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 182, 1284\u20131294.e1289 (2020).","journal-title":"Cell"},{"key":"923_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19808-4","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat. Commun. 11, 6013 (2020).","journal-title":"Nat. Commun."},{"key":"923_CR13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/sctm.19-0167","volume":"9","author":"J Cores","year":"2020","unstructured":"Cores, J. et al. A pre-investigational new drug study of lung spheroid cell therapy for treating pulmonary fibrosis. Stem Cells Transl. Med. 9, 786\u2013798 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"923_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637 (2004).","journal-title":"J. Pathol."},{"key":"923_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang, H., Penninger, J. M., Li, Y., Zhong, N. & Slutsky, A. S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 46, 586\u2013590 (2020).","journal-title":"Intensive Care Med."},{"key":"923_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"923_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16048-4","volume":"11","author":"C Lei","year":"2020","unstructured":"Lei, C. et al. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig. Nat. Commun. 11, 2070 (2020).","journal-title":"Nat. Commun."},{"key":"923_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.12688\/f1000research.22211.2","volume":"9","author":"RL Kruse","year":"2020","unstructured":"Kruse, R. L. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Research 9, 72 (2020).","journal-title":"F1000Research"},{"key":"923_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.addr.2015.04.001","volume":"90","author":"RH Fang","year":"2015","unstructured":"Fang, R. H., Luk, B. T., Hu, C.-M. J. & Zhang, L. Engineered nanoparticles mimicking cell membranes for toxin neutralization. Adv. Drug Deliv. Rev. 90, 69\u201380 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"923_CR20","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1021\/acsnano.0c01665","volume":"14","author":"L Rao","year":"2020","unstructured":"Rao, L., Tian, R. & Chen, X. Cell-membrane-mimicking nanodecoys against infectious diseases. ACS Nano 14, 2569\u20132574 (2020).","journal-title":"ACS Nano"},{"key":"923_CR21","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1021\/acs.nanolett.0c02278","volume":"20","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Cellular nanosponges inhibit SARS-CoV-2 infectivity. Nano Lett. 20, 5570\u20135574 (2020).","journal-title":"Nano Lett."},{"key":"923_CR22","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1021\/acs.nanolett.8b03913","volume":"19","author":"L Rao","year":"2019","unstructured":"Rao, L. et al. A biomimetic nanodecoy traps Zika virus to prevent viral infection and fetal microcephaly development. Nano Lett. 19, 2215\u20132222 (2019).","journal-title":"Nano Lett."},{"key":"923_CR23","doi-asserted-by":"publisher","first-page":"e1802233","DOI":"10.1002\/adma.201802233","volume":"30","author":"X Wei","year":"2018","unstructured":"Wei, X. et al. T-cell-mimicking nanoparticles can neutralize HIV infectivity. Adv. Mater. 30, e1802233 (2018).","journal-title":"Adv. Mater."},{"key":"923_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nbt.3037","volume":"33","author":"BD Henry","year":"2015","unstructured":"Henry, B. D. et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat. Biotechnol. 33, 81\u201388 (2015).","journal-title":"Nat. Biotechnol."},{"key":"923_CR25","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1073\/pnas.1323633111","volume":"111","author":"MJ Hoegger","year":"2014","unstructured":"Hoegger, M. J. et al. Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigs. Proc. Natl Acad. Sci. USA 111, 2355\u20132360 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"923_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/jamp.2009.0797","volume":"23","author":"M Geiser","year":"2010","unstructured":"Geiser, M. Update on macrophage clearance of inhaled micro- and nanoparticles. J. Aerosol Med. Pulm. Drug Deliv. 23, 207\u2013217 (2010).","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"923_CR27","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","volume":"7","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. Natl Sci. Rev. 7, 998\u20131002 (2020).","journal-title":"Natl Sci. Rev."},{"key":"923_CR28","doi-asserted-by":"publisher","first-page":"102833","DOI":"10.1016\/j.ebiom.2020.102833","volume":"57","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine 57, 102833 (2020).","journal-title":"EBioMedicine"},{"key":"923_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17834-w","volume":"11","author":"C Guo","year":"2020","unstructured":"Guo, C. et al. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nat. Commun. 11, 3924 (2020).","journal-title":"Nat. Commun."},{"key":"923_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-020-0732-3","volume":"15","author":"HF Florindo","year":"2020","unstructured":"Florindo, H. F. et al. Immune-mediated approaches against COVID-19. Nat. Nanotechnol. 15, 630\u2013645 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"923_CR31","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","volume":"15","author":"MD Shin","year":"2020","unstructured":"Shin, M. D. et al. COVID-19 vaccine development and a potential nanomaterial path forward. Nat. Nanotechnol. 15, 646\u2013655 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"923_CR32","doi-asserted-by":"publisher","first-page":"27141","DOI":"10.1073\/pnas.2014352117","volume":"117","author":"L Rao","year":"2020","unstructured":"Rao, L. et al. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc. Natl Acad. Sci. USA 117, 27141\u201327147 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-021-00923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-021-00923-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-021-00923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T06:07:00Z","timestamp":1628748420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-021-00923-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["923"],"URL":"https:\/\/doi.org\/10.1038\/s41565-021-00923-2","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.C. is a co-founder and equity holder of BreStem Therapeutics Inc. P.-U.C.D. reports compensation for consulting from BreStem Therapeutics Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}